Skip to main content
TipRanks
Go Ultimate75% OFF

Kiniksa Pharmaceuticals (KNSA) Drug Pipeline

620 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Kpl-387Pericarditis, Heart Diseases, Recurrent PericarditisPhase IINot Yet RecruitingTransition to KPL-387 Monotherapy Dosing & Administration StudyDec 02, 2025―
Kpl-387Recurrent Pericarditis, Pericarditis, Pericarditis Acutephase2AndPhase3RecruitingPhase 2/3 Study of KPL-387 in Recurrent PericarditisMay 29, 2025
AbiprubartSjögrens DiseasePhase IITerminatedA Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's DiseaseJul 25, 2024―
Kpl-404Arthritis, RheumatoidPhase IICompletedStudy to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase InhibitorJan 03, 2022―
MavrilimumabCovidphase2AndPhase3CompletedStudy of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammationJun 23, 2020―
Kpl-716Plaque Psoriasis, Lichen Simplex Chronicus, Chronic Idiopathic Urticaria, Chronic Idiopathic Pruritus, Lichen PlanusPhase IICompletedA Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic DiseasesFeb 27, 2019―
VixarelimabPrurigo Nodularis, PruritisPhase IICompletedStudy to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo NodularisJan 23, 2019―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Kiniksa Pharmaceuticals Ltd. Class A (KNSA) have in its pipeline
Kiniksa Pharmaceuticals KNSA is currently developing the following drugs: Kpl-387, Abiprubart, Kpl-404, Mavrilimumab, Kpl-716, Vixarelimab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.